Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00320801
Status:
TERMINATED
Last Update Posted:
2012-09-03
First Post:
2006-04-28
Brief Title:
Buprenorphine Transdermal Patches BTDS in Subjects With Osteoarthritis Pain Includes a 52-week Extension Phase
Sponsor:
Purdue Pharma LP
Organization:
Purdue Pharma LP
Organization Data
Organization:
Purdue Pharma LP
Class:
INDUSTRY
Study ID:
BUP3014 and BUP3014S
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Purdue Pharma LP
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None